1 traditional cardiovascular risk factors, and inflammation mediators.

2 g cascade that leads to the up-regulation of inflammation mediators.

3 icking and for characterizing the effects of inflammation mediators.

4  by introducing endothelium-bound CCN1 as an inflammation mediator and by demonstrating a role for pl

5 ncer cells express higher levels of numerous inflammation mediators and form larger tumors compared w

6 BBB model, we probed its disruption by neuro-inflammation mediators and ischemic conditions and measu

7  understand cell-type-specific regulation of inflammation mediators and shedding new light on the rol

8 ys a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformat

9 mergent serum interactome included key gouty inflammation mediators (C5, IL-1B, CXCL8, IL6).

10                 Th17 cells play a role as an inflammation mediator in a variety of autoimmune disorde

11                                  We compared inflammation mediators in CSF (cerebrospinal fluid obtai

12 o analyze the formation of the most relevant inflammation mediators including proteins and lipids in

13 traditional cardiovascular risk factors, and inflammation mediators (P < 0.001), but concentrations o

14 nist of COX-2, catalyzing the degradation of inflammation mediator prostaglandin E2 (PGE2) and other

15          Macrophages are the major source of inflammation mediators that are important in the pathoge

16           The effects of TSG-6, OPG, and the inflammation mediators TNFalpha, interleukin-1 (IL-1), a

17                                           29 inflammation mediators were measured using Luminex immun